|
Bristol-Myers Squibb Foundation Launches $100 Million Initiative Targeting America's Type 2 Diabetes Crisis
|
11 November 2010 |
|
Simcere and Bristol-Myers Squibb Enter Innovative Partnership to Develop Early-Stage Oncology Compound
|
03 November 2010 |
|
Bristol-Myers Squibb Third Quarter Featured Solid Operating Performance
|
27 October 2010 |
|
Bristol-Myers Squibb Begins Tender Offer to Acquire ZymoGenetics, Inc.
|
10 September 2010 |
|
Bristol-Myers Squibb to Acquire ZymoGenetics
|
08 September 2010 |
|
Bristol-Myers Squibb and Pfizer Inc Evaluate Unmet Need in Patients with Atrial Fibrillation
|
26 August 2010 |
|
Ipilimumab Receives FDA Priority Review Designation
|
19 August 2010 |
|
Bristol-Myers Squibb Second Quarter Featured Robust Clinical Data and Double-Digit EPS Growth
|
23 July 2010 |
|
ONGLYZA (saxagliptin) with Metformin as Initial Combination Therapy
|
28 June 2010 |
|
Bristol-Myers Squibb Signs Agreements with ICON and PAREXEL
|
15 June 2010 |
|
AVERROES Study Closes Early Due to Clear Evidence of Efficacy
|
11 June 2010 |
|
Bristol-Myers Squibb Reports Strong Sales, Earnings Performance in First Quarter
|
03 May 2010 |
|
Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus
|
10 March 2010 |
|
Bristol-Myers Squibb and Allergan Enter Global Agreement
|
05 March 2010 |
|
FDA Advisory Committee Recommends Approval of Belatacept
|
03 March 2010 |
|
Bristol-Myers Squibb supporting efforts to help survivors
|
21 January 2010 |
|
Facet Biotech and Bristol-Myers Squibb Report Promising Phase I/II Interim Data for Elotuzumab
|
08 December 2009 |
|
"Positive Charge" to Help Address Barriers and Provide Support to People Living with HIV/AIDS
|
01 December 2009 |
|
Bristol-Myers Squibb and Alder Biopharmaceuticals Enter Global Agreement
|
11 November 2009 |
|
Bristol-Myers Squibb Achieves Strong Sales
|
23 October 2009 |